Benefits of the Mediterranean diet beyond the Mediterranean Sea and beyond food patterns by Martinez-Gonzalez, M.A. (Miguel Ángel)
COMMENTARY Open Access
Benefits of the Mediterranean diet beyond
the Mediterranean Sea and beyond food
patterns
Miguel A. Martínez-González1,2,3
Abstract
Abundant and growing evidence has accrued to demonstrate that the traditional Mediterranean diet is likely to be the
ideal dietary pattern for the prevention of cardiovascular disease. A landmark randomized trial (PREDIMED) together
with many well-conducted long-term observational prospective cohort studies support this causal effect.
A new, large British cohort study by Tong et al. assessing the association between adherence to the Mediterranean diet
and cardiovascular disease was recently published in BMC Medicine. Using a superb methodology, they followed-up
23,902 participants for 12.2 years on average and observed several thousand incident cases.
The results of this cohort study showed a significant beneficial effect of the Mediterranean diet on cardiovascular
events. These findings support the transferability of this dietary pattern beyond the shores of the Mediterranean Sea.
The authors provided measures of population impact in cardiovascular prevention and estimated that 19,375 cases of
cardiovascular death would be prevented each year in the UK by promoting the Mediterranean Diet.
Please see related article: http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0677-4.
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Background
The huge toll of death and disability caused each year by
cardiovascular disease (CVD) continues to represent a
great humiliation for public health. More people die an-
nually from CVDs than from any other cause, and global
projections are somber with a projected increase from
17 million to more than 24 million yearly CVD deaths in
2030 [1, 2]. Not a minor part of this humiliation comes
from the knowledge that CVD can largely be prevented
by timely population changes in metabolic risk factors
including obesity, hypertension, dyslipidemia, and dia-
betes. This unambiguously indicates the need to address
unhealthy lifestyles and replace unhealthy food patterns
with their healthiest alternatives [3].
In this context, strong evidence supports the trad-
itional Mediterranean diet (MedDiet) as the optimal
choice for preventing CVD [3, 4]. Two decades ago, the
Lyon diet-heart study, a randomized controlled clinical
trial, was unique in showing that a dietary intervention
brought about a dramatic reduction in cardiovascular
events among survivors of a previous myocardial infarc-
tion [5]. The dietary intervention was based on the Med-
Diet. Subsequently, many prospective cohort studies have
consistently confirmed the cardiovascular benefits of the
traditional MedDiet. These cohort studies (pooled in dif-
ferent meta-analyses) constitute an impressive accrual of
high-quality epidemiological evidence, currently not avail-
able for any other dietary pattern [6–11] and meet the
classical criteria for causality in epidemiology [12]. How-
ever, for a long time, the only available evidence on cardio-
vascular prevention by the MedDiet was exclusively based
on observational designs (with the single exception of the
Lyon study). Observational studies can be affected by
some biases, particularly measurement errors and residual
confounding. But, this potential objection was only
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tenable until 2013, when the final results of the PRE-
DIMED (“Prevencion con Dieta Mediterranea”) primary
prevention trial were published [13]. This landmark trial
included 7447 participants and showed a 30 % relative re-
duction in the risk of hard CVD events during 4.8 years of
follow-up. Most hesitations about and criticisms of previ-
ous observational designs were removed by the almost
perfect consistency between well-conducted observational
cohort studies and trials. This consistency is of paramount
importance for supporting the validity of well-conducted
observational cohort studies in nutritional epidemiology
as well as for evidence-based health promotion [8, 12, 14].
A review summarizing only the cohort studies published
during 2015 and the first months of 2016 identified 19
new prospective studies on the traditional MedDiet [15].
Substantial benefits were observed with regards to myo-
cardial infarction, stroke, heart failure, and total mortality.
The pending challenge was to test if the proven benefits
of the MedDiet were restricted to populations living in
Mediterranean areas or whether they were fully transfer-
able far beyond the shores of the Mediterranean Sea. An
excellent positive answer to this question is found in the
new results from the EPIC-Norfolk cohort study [16].
In a UK general population setting, Tong et al. evaluated
23,902 participants followed-up for 12.2 years on average
and observed several thousand new cases of CVD and
1714 CVD deaths. MedDiet adherence (repeatedly evalu-
ated during follow-up) was inversely associated with hard
clinical cardiovascular events (a composite end-point in-
cluding ischemic heart disease [IHD], ischemic stroke,
hemorrhagic stroke, heart failure, peripheral vascular dis-
ease, and other CVD events) [16]. The design, conduction,
epidemiological/statistical analyses, and interpretation of
findings in this study are superb. The authors are to be
commended for their excellent work. Interestingly, they
included absolute measures of risk reduction, potential
impact (population attributable fractions [PAF]), and
number needed to treat, under the assumption of a truly
causal protective effect of the MedDiet on CVD. Approxi-
mately 8.5 % of incident IHD or stroke events in the
UK were attributable to low adherence to the Med-
Diet (equivalent to 10.2 IHD or stroke cases prevent-
able per 1000 population). They estimated that 19,375
cases of CVD death would be prevented each year by
promoting the MedDiet in the UK.
Further strengths of the study by Tong et al. [16] in-
clude its long-term follow-up, optimal ascertainment of
outcomes, careful adjustment for a wide array of poten-
tial confounders, considerations to potential competing
risks, and, in particular, the diverse sensitivity analyses
using different definitions of the MedDiet. It is reassur-
ing that benefits were similar upon alternative categori-
zations of food groups in four scores of the MedDiet.
However, the profile of a traditional MedDiet may be
different in the UK than in Southern European countries
and further questions about transferability still remain.
This may explain why some magnitudes of effect were
inferior to those from the PREDIMED trial [9].
It is a fact that culinary practices, average intakes (and
consequently the cut-off points used for computing
scores), serving sizes, and combinations of foods are likely
to be different in studies conducted in Mediterranean set-
tings than in those conducted beyond the shores of the
Mediterranean Sea. Despite this, Tong et al. have pre-
sented an excellent study that has obtained salient results
with practical consequences for nutrition policy after
using food frequency questionnaires (FFQs) habitually
applied in sound studies of nutritional epidemiology.
Well-validated FFQs represent a valid and realistic tool for
nutritional assessment in large longitudinal studies and
randomized trials in nutrition [14].
Conclusions and future directions
Practical consequences of the study by Tong et al. for nu-
trition policies are that healthy natural fats typical of the
MedDiet (extra-virgin olive oil, tree nuts, and fatty fish) can
now be more confidently promoted in the UK. We should
also allay fears regarding a moderate and usual consump-
tion of red wine spread out over the week, following the
traditional Mediterranean alcohol-drinking pattern [17].
Also, there are strong reasons to promote an abundance of
plant foods, especially fresh fruits as the usual dessert.
Conversely, there is a need to substantially reduce the
consumption of meat, especially red and processed meats,
ice creams, fizzy soft drinks, sugary desserts, sweet biscuits,
other commercial bakery, cream pies and cakes [16].
The first future direction in research is that a large
randomized trial with MedDiet and hard clinical events
is needed beyond the Mediterranean Sea. The US
National Institutes of Health are planning to soon
launch such a trial in the US [18]. This initiative is very
much welcomed and there is preliminary evidence in
favor of the transferability of the MedDiet (including
extra virgin olive oil and tree nuts) to the US [19].
Second, there is a need to go not only beyond the
Mediterranean Sea (as the EPIC-Norfolk study did) but
also beyond the MedDiet and beyond food patterns. After
the successful results of interventions with MedDiet, even
if weight loss, caloric restriction, or physical activity were
not included [9], it is very likely that an energy-restricted
MedDiet with physical activity and weight loss might be
an optimal intervention. A large lifestyle multifactorial
trial going beyond food patterns would be of high interest.
There is, in fact, an urgent need for such a trial because
most doctors are setting goals for weight loss and exercise
for their overweight patients, but there is no large long-
term randomized trial showing a reduction in cardiovas-
cular clinical events with these interventions.
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Fortunately, a large trial focused on MedDiet, weight
loss, and physical activity (PREDIMED-PLUS) is ongoing,
and it has already randomized 6000 participants [20]. The
results of the EPIC-Norfolk study and the expected results
of PREDIMED-PLUS may represent powerful evidence-
based answers to what is currently the most important
question for public health: how to effectively tackle
chronic diseases. These answers are likely to be strong
enough to eventually reverse the deep humiliation for
public health that the burden of CVD represents.
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